Plans for Drug Discovery Building move
forward
The Drug Discovery Building (DDB) will contain 114,000-square-feet and be comprised of a laboratory and biotech start-up space.
Breaking ceremonial
ground for the Drug Discovery Building Oct. 3 are Dr. John Raymond,
from left, vice president for academic affairs and provost; Dr. Andrew
Kraft, director, Hollings Cancer Center; Dr. Rick Schnellmann,
chairman, Pharmaceutical and Biomedical Sciences; Dr. Ray Greenberg,
MUSC president; and Dr. Charles Thomas Jr., chairman, MUSC Board of
Trustees. DDB is scheduled for completion in 2010. Visit http://research.musc.edu/oroa/ddb.html.The first floor will house the pharmacy teaching laboratories and an auditorium. The second floor will include structural biology laboratories and space for biotech start-up companies.
Level three will house cancer research laboratories. The fourth floor will hold the high-throughput screening core, medicinal chemistry laboratories, and experimental therapeutics in cancer laboratories. Level five will be home to advanced cellular technologies and organ failure research laboratories. The sixth floor will hold the animal facility. There also will be space for the South Carolina College of Pharmacy.
Friday, Oct. 10, 2008
Catalyst Online is published weekly,
updated
as needed and improved from time to time by the MUSC Office of Public
Relations
for the faculty, employees and students of the Medical University of
South
Carolina. Catalyst Online editor, Kim Draughn, can be reached at
792-4107
or by email, catalyst@musc.edu. Editorial copy can be submitted to
Catalyst
Online and to The Catalyst in print by fax, 792-6723, or by email to
catalyst@musc.edu. To place an ad in The Catalyst hardcopy, call Island
Publications at 849-1778, ext. 201.